Tyler’s Law would require the Secretary of Health and Human Services to study whether hospital emergency departments should routinely test overdose patients for fentanyl. The study must examine how often fentanyl testing is already used, what it costs, what benefits and risks it may have, and how it affects patient privacy and the doctor-patient relationship. Within 6 months after that study is finished, HHS would have to issue guidance on whether emergency departments should make fentanyl testing a routine practice and how hospitals can make sure clinicians know what substances are being tested for. The bill does not mandate nationwide testing directly, but it sets up a federal review and guidance process that could shape emergency room practice.
What This Bill Does
- HHS must complete a study within 1 year of enactment.
- The study must examine how often ERs test for fentanyl during overdoses.
- The study must look at costs, benefits, risks, privacy, and the patient-physician relationship.
- Within 6 months after the study, HHS must issue guidance on routine fentanyl testing.
- The bill defines hospital emergency department by reference to Social Security Act section 1867(a).
Who This Bill Affects
If you or someone in your family ever comes to a hospital emergency department after an overdose, this bill could affect whether fentanyl testing is used as a routine part of care and how that information is handled. It does not create a new payment or eligibility program for the public, but it could lead to new federal guidance that influences what tests hospitals order, what clinicians know in real time, and how privacy protections are applied to overdose patients.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Emergency physicians and hospital clinicians They may support the bill because a fentanyl test can help confirm what substance is driving an overdose and guide treatment decisions. Federal guidance could also reduce uncertainty about when testing is appropriate and how to interpret routine drug screens.
- Public health and overdose prevention advocates They may argue that clearer identification of fentanyl exposure can improve clinical response and help reduce future overdose risk. A national study could also bring more consistency to emergency room practice across hospitals.
- Families affected by overdose They may want hospitals to detect fentanyl quickly so they understand what happened and can better plan follow-up care. The bill’s focus on patient outcomes and future overdose risk may appeal to people seeking stronger emergency intervention.
- Hospital administrators They may worry that a new routine testing expectation could add costs, staffing burden, or lab demands without enough evidence that outcomes improve. Hospitals may also be concerned about how guidance could affect existing workflows in busy emergency departments.
- Privacy and patient-rights advocates They may caution that broader testing could increase concerns about confidentiality and how sensitive overdose information is used. The bill itself recognizes that privacy and the patient-physician relationship are important issues to study.
- Clinicians concerned about test interpretation Some providers may argue that any new routine screening must clearly explain what substances are included and how results should be used. They may worry that incomplete understanding of drug panels could lead to confusion in care decisions or patient communication.
Key Implications
-
““complete a study to determine””
HHS would have to gather evidence before issuing policy guidance, so the bill is not an immediate testing mandate. The first real-world effect would be a federal review of current hospital practices and evidence gaps.
-
““how frequently hospital emergency departments test for fentanyl””
The bill focuses on whether fentanyl testing is already happening in overdose cases and how widespread it is. That means the government would be measuring practice patterns, not just making an abstract recommendation.
-
““the costs associated with such testing””
Cost is explicitly part of the study, which signals that the bill could influence hospital budgeting and lab procedures. If testing is shown to be useful, hospitals may still need to absorb added expense or justify billing changes.
-
““protections for the confidentiality and privacy””
Congress is signaling that overdose testing raises sensitive data issues. Any guidance could affect how results are disclosed, recorded, and shared within the care team.
-
““Whether hospital emergency departments should implement fentanyl testing as a routine procedure””
This is the bill’s central policy question. The resulting HHS guidance could shape whether fentanyl testing becomes a standard part of overdose evaluation in emergency rooms.
Official Source & Bill Facts
BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.
- Bill
- HR 2004
- Congress
- 119th Congress
- Official title
- Tyler’s Law
- Policy area
- Healthcare
- Latest action
- Forwarded by Subcommittee to Full Committee by Voice Vote. (June 25, 2026)
- Last updated
- June 27, 2026
Latest Status
June 25, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
Related Bills
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.